Arrowhead Pharmaceuticals, Inc. (LON:0HI3)
London · Delayed Price · Currency is GBP · Price in USD 67.80
-1.66 (-2.39%)
Feb 6, 2026, 4:31 PM GMT
Arrowhead Pharmaceuticals Market Cap
Arrowhead Pharmaceuticals has a market cap or net worth of 6.69 billion as of February 6, 2026. Its market cap has increased by 235.72% in one year.
Market Cap
6.69B
Enterprise Value
6.51B
Revenue
810.60M
Ranking
n/a
PE Ratio
44.49
Stock Price
67.80
Market Cap Chart
Since January 13, 2004, Arrowhead Pharmaceuticals's market cap has increased from 17.94M to 6.69B, an increase of 37,156.93%. That is a compound annual growth rate of 30.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 6.68B | -0.27% |
| Dec 31, 2025 | 6.70B | 258.70% |
| Dec 31, 2024 | 1.87B | -27.60% |
| Dec 29, 2023 | 2.58B | -27.67% |
| Dec 30, 2022 | 3.57B | -30.28% |
| Dec 31, 2021 | 5.12B | -11.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genus | 2.05B |
| Oxford Nanopore Technologies | 1.48B |
| Oxford Biomedica | 987.76M |
| PureTech Health | 319.51M |
| Avacta Group | 247.13M |
| Faron Pharmaceuticals Oy | 193.94M |
| Scancell Holdings | 137.51M |
| Bioventix | 92.74M |